A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
Recruiting · NCT07023315 · Registry updated 2026-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm | Recruiting | Phase 3 | 2026-02-11 | NCT07023315 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akeso | 89 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fourth Hospital of Hebei Medical University | Shijiazhuang | China | 4 |
| Fujian Provincial Cancer Hospital | Fuzhou | China | 10 |
| Harbin Medical University Cancer Hospital | Harbin | China | 51 |
| Peking University Cancer Hospital | Beijing | China | 2 |
| Tianjin Provincial Tumor Hospital | Tianjin | China | 1 |
| Zhongshan Hospital, Fudan University | Shanghai | China | 15 |